Abstract
Clostridium difficile infection (CDI) has been increasing in incidence over the past three decades. It is now recognized as a major healthcare-associated complication and is the leading nosocomial pathogen. Disease severity ranges from mild diarrhea to severe sepsis with multiple organ dysfunction. Early recognition, diagnosis, and treatment are necessary to prevent disease progression. Despite best effort, some cases progress in severity, and the development of severe, complicated disease (sometimes known as fulminant colitis or the development of toxic megacolon) is associated with a high rate of mortality. Surgical treatment for severe, complicated disease was defined in the 1990s to be subtotal abdominal colectomy and end ileostomy. Although mortality is improved by colectomy in patients that are critically ill compared to those treated with medical therapy alone, outcomes are still poor. There may be opportunity to improve outcomes by more aggressive nonsurgical interventions, earlier surgical intervention, and alternative surgical techniques when managing severe CDI. This chapter highlights some of the minimally invasive surgical and nonsurgical approaches to treat patients with severe, complicated CDI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Key References
Leffler DA, Lamont JT. Clostridium difficile Infection. N Engl J Med. 2015;372:1539–48.
Carter GP, et al. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. MBio. 2015;6:1–10.
Lim SK, et al. Emergence of a ribotype 244 strain of clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis. 2014;58:1723–30.
Surawicz CM, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–98.
Cornely OA, et al. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. J Antimicrob Chemother. 2014;69:2892–900.
Soriano MM, Danziger LH, Gerding DN, Johnson S. Novel Fidaxomicin treatment regimens for patients with multiple Clostridium difficile infection recurrences that are refractory to standard therapies. Open Forum Infect Dis. 2014;1:ofu069.
Drekonja D, et al. Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med. 2015;162:630–8.
van Nood E, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–15.
Waltz P, Zuckerbraun B. Novel therapies for severe Clostridium difficile colitis. Curr Opin Crit Care. 2016;22:167–73.
Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage. Ann Surg. 2011;254:423–9.
Remzi FH, et al. Current indications for blow-hole colostomy:ileostomy procedure. A single center experience. Int J Colorectal Dis. 2003;18:361–4.
Oppermann TE, Christopherson WA, Stahlfeld KR. Fulminant Clostridium difficile colitis isolated to the ascending colon by a diverting transverse loop colostomy. Am Surg. 2009;75:859–60.
Kim PK, et al. Intracolonic vancomycin for severe Clostridium difficile colitis. Surg Infect. 2013;14:532–9.
Causey MW, et al. Colonic decompression and direct intraluminal medical therapy for Clostridium difficile-associated megacolon using a tube placed endoscopically in the proximal colon. Color Dis. 2014;16:71–4.
Julien M, et al. Severe complicated clostridium difficile infection: can the UPMC proposed scoring system predict the need for surgery? J Trauma Acute Care Surg. 2016; doi:10.1097/TA.0000000000001112.
Kassam Z, et al. Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection. Aliment Pharmacol Ther. 2016;43:725–33.
Miller MA, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148.
van der Wilden GM, et al. Fulminant Clostridium difficile colitis: prospective development of a risk scoring system. J Trauma Acute Care Surg. 2014;76:424–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Waltz, P., Zuckerbraun, B.S. (2018). Minimally Invasive Approaches to Clostridium Difficile Colitis. In: Khwaja, K., Diaz, J. (eds) Minimally Invasive Acute Care Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-64723-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-64723-4_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64721-0
Online ISBN: 978-3-319-64723-4
eBook Packages: MedicineMedicine (R0)